Brief: Karolinska Development Says Anacardio Reports Positive Phase 2A Trial Results
10/12/2025 07:10
Dec 10 (Reuters) - Karolinska Development AB KDEV.ST: ANACARDIO REPORTS POSITIVE PHASE 2A TRIAL RESULTS FOR AC01 STUDY MEETS PRIMARY ENDPOINT WITH FAVORABLE SAFETY PROFILE Source text: ID:nGNEbkSphW Further company coverage: KDEV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Kdventures AB
See all newsRefile: BRIEF-Umecrine Cognition Gets Notice Of Allowance In US
Brief: KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study
Brief: KDventures' AnaCardio Raises €62.5 Million
Brief: Kdventures' Umecrine Cognition Gets Two USPTO Notices Of Allowance For Patent Applications
Brief: Kdventures' Modus Therapeutics Carries Out Directed Issue